A simulation study of the cost of cerebral vasospasm treatments with clazosentan: A mathematical model using time-driven activity-based costing
Fig 2
Decision tree model for the treatment of aneurysmal subarachnoid haemorrhage.
Half of the patients received clazosentan following coiling or clipping and subsequently transitioned to either recovery or symptomatic cerebral vasospasm (sVSP), based on the probabilities indicated at each node (black circles). Claz, clazosentan.